MJJ
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
CIN assigns Microsectors Cannabis 3x ETN a Neutral rating with low conviction, reflecting a composite score in the low forties. Regulatory is the strongest pillar, reaching the mid-fifties on a favorable global jurisdiction posture and a clean enforcement profile. Fundamentals and market support each sit near forty, leaving neither pillar strong enough to broaden the case. Editorial support ranks lowest at roughly thirty because CIN newsroom coverage contains no recent newsroom or brief activity. The resulting profile supports the Neutral band: regulatory structure provides relative stability, while absent operating, pricing, and editorial confirmation caps conviction.
Underlying data remain sparse. Licensed fundamentals data provide no revenue growth, margin, or financial-condition evidence for the instrument, preventing the fundamentals pillar from establishing an operating trend. Institutional pricing feeds provide no current quote, so the market pillar cannot assess momentum, volatility, or price confirmation. Filing cadence is the principal regulatory weakness. Primary regulatory filings show no latest filing date, while the trailing ninety-day and 180-day windows contain no recorded events. That inactivity drives the cadence subscore into the mid-twenties despite a jurisdiction score near seventy and an enforcement subscore near eighty. The absence of enforcement hits supports the regulatory pillar, but it does not substitute for current filing activity. CIN newsroom coverage also records no newsroom hits or briefs, reinforcing the limited information flow reflected in the editorial score.
The forward catalyst rests squarely on regulatory disclosure, the highest-rated pillar. A newly dated primary regulatory filing would lift cadence from its depressed level, refresh the instrument’s disclosure record, and validate the stronger jurisdiction and enforcement components already carrying the rating. That improvement could raise conviction without relying on unavailable revenue, margin, or quote data. Conversely, continued filing inactivity would preserve the current imbalance between favorable regulatory posture and weak disclosure frequency, keeping the composite anchored in Neutral territory. The single most important signal to watch is the appearance of a newly dated primary regulatory filing.
- IR / PR agency
- Gregory FCA
- IR email
- info@rexshares.com
- IR page
- Investor relations
- Headquarters
- 777 Brickell Ave Miami, FL 33131
- Phone
- 1-877-369-5412
- CEO
- Greg King Founder
- CFO
- Robert Rokose
- Website
- Company website
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for MJJ (MJJ)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for MJJ (MJJ), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Neutral / Wait. Mixed data profile. Await clearer directional signal. (0 bullish signals, 0 bearish signals.)
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for MJJ are maintained by Cannabis Investor News and refreshed throughout the trading day.